Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.1 USD | -5.53% | -17.00% | -68.32% |
Apr. 16 | Windtree Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 11 | North American Morning Briefing : Stock Futures -2- | DJ |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 2.09M |
---|---|---|---|---|---|
Net income 2024 * | -21M | Net income 2025 * | -29M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.23
x | P/E ratio 2025 * |
-0.35
x | Employees | 20 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.34% |
Latest transcript on Windtree Therapeutics, Inc.
1 day | -5.53% | ||
1 week | -17.00% | ||
Current month | -19.05% | ||
1 month | -40.06% | ||
3 months | -36.73% | ||
6 months | -77.19% | ||
Current year | -68.32% |
Managers | Title | Age | Since |
---|---|---|---|
Craig Fraser
CEO | Chief Executive Officer | 59 | 16-01-31 |
Eric Curtis
COO | Chief Operating Officer | 56 | 20-03-08 |
George Cox
CTO | Chief Tech/Sci/R&D Officer | 73 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Scott
BRD | Director/Board Member | 70 | 21-02-02 |
Mark Strobeck
BRD | Director/Board Member | 53 | 23-06-21 |
Leslie Williams
BRD | Director/Board Member | 64 | 21-02-02 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 4.1 | -5.53% | 16,798 |
24-05-09 | 4.34 | -9.01% | 55,891 |
24-05-08 | 4.77 | +8.41% | 37,843 |
24-05-07 | 4.4 | -9.74% | 177,930 |
24-05-06 | 4.875 | -1.32% | 29,418 |
Delayed Quote Nasdaq, May 10, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-68.32% | 2.09M | |
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- WINT Stock